SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950142-21-003501
Filing Date
2021-11-02
Accepted
2021-11-02 16:02:52
Documents
1
Group Members
DANIEL JAVITTJONATHAN C. JAVITT

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 eh210197009_13da1-nrx.htm SC 13D/A 75766
  Complete submission text file 0000950142-21-003501.txt   77232
Mailing Address 1201 NORTH MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address
Javitt Jonathan C (Filed by) CIK: 0001303782 (see all company filings)

Type: SC 13D/A

Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Subject) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90195 | Film No.: 211371129
SIC: 2834 Pharmaceutical Preparations